OPGN OpGen Inc

OpGen, Inc. (NASDAQ:OPGN) today announced that it will report its first quarter 2017 financial results after close of market on Wednesday, April 26, 2017. OpGen’s management team will host a live conference call and webcast at 4:30 p.m. Eastern Time to discuss the company’s financial results and business progress.

Dial-in InformationU.S. Dial-In Number: 844-420-8185International Dial-In Number: 216-562-0481Conference ID: 11373581

Replay Dial-In InformationU.S. Dial-In Number: 855-859-2056International Dial-In Number: 404-537-3406Conference ID: 11373581

The live, listen-only webcast of the conference call may also be accessed by visiting the investors section of the company’s website at http://ir.opgen.com. A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company’s website for 90 days.

About OpGenOpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. Learn more at www.opgen.com and follow OpGen on Twitter and LinkedIn. 

Company Contact: 
Michael Farmer
Director, Marketing
(240) 813-1284 
mfarmer@opgen.com
InvestorRelations@opgen.com
            
Investor and Media Contact: 
MacDougall Biomedical Communications 
Cammy Duong
781-591-3443
cduong@macbiocom.com